LEADER 01206nam  2200325z- 450 
001 9910694094103321
005 20060622170631.0
035   $a(CKB)5860000000028155
035   $a(BIP)013636521
035   $a(EXLCZ)995860000000028155
100   $a20220406c2005uuuu  -u-         -
101 0 $aeng
200 10$aMedicaid prescription drugs $eexamining options for payment reform : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, June 22, 2005
215   $a1 online resource (iii, 107 p.) $cill
311   $a0-16-074023-1 
517   $aMedicaid prescription drugs 
606   $aMedicaid$xClaims administration
606   $aPrescription pricing$zUnited States
610   $aMedicaid
610   $aDrugs
610   $aPricing
610   $aMedical
610   $aBusiness & economics
615  0$aMedicaid$xClaims administration.
615  0$aPrescription pricing
712 02$aUnited States, Congress House Committee on Energy and Commerce Subcommittee on Health Staff,$4oth
906   $aBOOK
912   $a9910694094103321
996   $aMedicaid prescription drugs$93200996
997   $aUNINA